$12.870
-0.236 (-1.83%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NTLA Prediction & Forecast by Similar Chart Analysis
Alphio's NTLA stock price prediction model matches the current Intellia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.87 (+0.03%). The 1-week path is $12.82 (-0.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Intellia Therapeutics Inc Stock?
Intellia Therapeutics Inc is currently priced at $12.87, which is below the average analyst price target of $17, indicating potential upside. However, the company has a negative net income of -106634000 USD in Q2 2026 and a concerning insider selling increase of 2235.78%, which raises risks for investors. Given these mixed signals, it's prudent to hold rather than buy at this time.
NTLA stock price ended at $12.87 on Friday, after losing -1.83%
Intellia Therapeutics Inc (NTLA) last closed at $12.87, losing -1.83%. These facts feed the 1-day and 1-week NTLA price prediction above.
Analyst Consensus
Intellia Therapeutics Inc (NTLA): 4 buy, 2 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Intellia Therapeutics Inc (NTLA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches NTLA, ranked by similarity.
Seasonality analysis for NTLA
Historically the probability of a positive August return for NTLA is 31.75%. October offers the highest probability of a positive month at 50.00%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.